A HIF1-alpha Regulatory Loop Links Hypoxiaand Mitochondrial Signals in Pheochromocytomas
暂无分享,去创建一个
Andrew L. Kung | Sandro Santagata | James F. Powers | Kenneth N. Ross | Diana E. Benn | Deborah J. Marsh | Bruce G. Robinson | Marta Barontini | Patricia L. M. Dahia | Cesar Y. Hayashida | Gabriela Sanso | Matthew E. Wright | K. Ross | S. Santagata | A. Kung | D. Marsh | B. Robinson | P. M. Dahia | M. Wright | C. Y. Hayashida | M. Barontini | G. Sansó | J. Powers | D. Benn | Patricia L. M. Dahia | James F. Powers | Matthew E. Wright | P. Dahia | M. E. Wright
[1] Shridar Ganesan,et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. , 2005, Genes & development.
[2] Okio Hino,et al. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. , 2005, Cancer research.
[3] W. Kaelin,et al. Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth , 2003, PLoS biology.
[4] Kan Ding,et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice , 2003, Nature Genetics.
[5] B. Lemire,et al. The Ubiquinone-binding Site of the Saccharomyces cerevisiae Succinate-Ubiquinone Oxidoreductase Is a Source of Superoxide* , 2003, Journal of Biological Chemistry.
[6] Marjan S. Bolouri,et al. Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.
[7] P. Hogendoorn,et al. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology , 2003, The Journal of pathology.
[8] W. Kaelin,et al. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. , 2003, Journal of the American Society of Nephrology : JASN.
[9] N. Socci,et al. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. , 2003, Molecular cell.
[10] P. Rustin,et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. , 2003, Cancer research.
[11] K. Nathanson,et al. Pheochromocytoma: the expanding genetic differential diagnosis. , 2003, Journal of the National Cancer Institute.
[12] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[13] George M. Hilliard,et al. Cobalt Inhibits the Interaction between Hypoxia-inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-α* , 2003, The Journal of Biological Chemistry.
[14] S. Iwata,et al. Architecture of Succinate Dehydrogenase and Reactive Oxygen Species Generation , 2003, Science.
[15] P. Rustin,et al. Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. , 2002, The Journal of clinical endocrinology and metabolism.
[16] W. Kaelin,et al. Molecular basis of the VHL hereditary cancer syndrome , 2002, Nature Reviews Cancer.
[17] G. Semenza. Signal transduction to hypoxia-inducible factor 1. , 2002, Biochemical pharmacology.
[18] Mirna Lechpammer,et al. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. , 2002, Cancer cell.
[19] P. Rustin,et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.
[20] P. Ratcliffe,et al. Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.
[21] E S Husebye,et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.
[22] R. Aguiar,et al. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas. , 2001, The Journal of clinical endocrinology and metabolism.
[23] M. Ivan,et al. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. , 2001, Human molecular genetics.
[24] P. Ratcliffe,et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. , 2001, Human molecular genetics.
[25] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[26] M. Ivan,et al. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.
[27] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Tischler,et al. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice , 2000, Cell and Tissue Research.
[29] V. de Franciscis,et al. Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells* , 2000, The Journal of Biological Chemistry.
[30] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[31] B. Ackrell. Progress in understanding structure–function relationships in respiratory chain complex II , 2000, FEBS letters.
[32] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[33] J. Ritz,et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. , 1999, Human molecular genetics.
[34] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] Michio Tsuda,et al. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes , 1998, Nature.
[36] S. Chew,et al. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. , 1995, Journal of medical genetics.
[37] M. Wigler,et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.
[38] P. Kunkel,et al. Pheochromocytoma * , 1951, Intensive Care Medicine.
[39] J. Mesirov,et al. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis , 2005, Nature Genetics.
[40] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[41] L. Aaltonen,et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. , 2004, American journal of human genetics.
[42] E. Lander,et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.
[43] C. Li,et al. Feature extraction and normalization algorithms for high‐density oligonucleotide gene expression array data , 2001, Journal of cellular biochemistry. Supplement.